News
Media
Conferences
Resources
Publications
Events
Business
Practice Type
Subscribe
Total Pharmacy

Aleksandra Bieniek, PharmD

Articles by Aleksandra Bieniek, PharmD

First-in-Class Treatment for Obstructive Hypertrophic Cardiomyopathy Is Approved by FDA

ByAleksandra Bieniek, PharmD,Kevin Chamberlain, PharmD, FASCP

October 11th 2022

Mavacamten improves functional capacity and symptoms in adults with New York Heart Association class II-III obstructive HCM.

Latest Updated Articles

First-in-Class Treatment for Obstructive Hypertrophic Cardiomyopathy Is Approved by FDA
Published: October 11th 2022 | Updated:

Trending on Drug Topics

Targeted Coordination Is Crucial in Boosting Pneumococcal Vaccine Coverage

The Providers, Representation Needed to Normalize HIV Care, Prevention

Pneumococcal: Most-Read Stories of 2025

Wegovy Pill Receives FDA Approval as First Oral GLP-1 for Weight-Loss

Women’s Health: Top Stories of 2025